Un-audited Financial Results for the quarter and half financial year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 4.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jaysynth Orgochem reported Q2 FY26 standalone revenue of ₹6,604 lakhs, up ~10.8% YoY from ₹5,962 lakhs, while H1 FY26 revenue grew ~13.1% to ₹12,381 lakhs. Standalone Q2 PAT rose ~23% YoY to ₹513.93 lakhs, though H1 PAT was largely flat at ₹699.87 lakhs versus ₹672.61 lakhs last year. The limited review report by M/s A H J & Associates is clean with no qualifications. However, operating cash flow turned sharply negative at ₹(1,112) lakhs standalone (vs ₹(151) lakhs in H1 FY25), and cash and cash equivalents nearly halved from ₹1,671 lakhs to ₹769 lakhs over the six months, pointing to significant working capital absorption. The company operates in two segments — Colorants & Chemicals and Inkjet Printers.
Revenue and profit growth are healthy on the surface, but the steep drop in operating cash flow and halving of cash reserves raise working capital and liquidity concerns for shareholders. Near-term stock sentiment may be cautious despite the clean audit opinion, as the quality of earnings looks weaker than the headline numbers suggest.